AbbVie Inc. (ABBV)
286.00 USD -0.98%
AbbVie Inc. fell 0.98% in the latest session, at 286.00 USD. By market cap it is number 3 of the 8 health care stocks on the S&P 500 heatmap. Its trailing P/E of 49.1 is above the median of those peers (40.7). The price is 4.3% below its 52-week high.
Key numbers
- Price
- 286.00 USD
- Day change
- -0.98% (-2.84)
- Market cap
- 505B USD
- P/E (trailing)
- 49.1
- P/E (forward)
- 17.7
- Dividend yield
- 2.40%
- 50-day average
- 269.77
- 200-day average
- 237.46
- 52-week range
- 190.75 – 298.74
- Dividend per share (annual)
- 6.92 USD
Data as of 3 Nov 2026, 22:00 CET. Market data may be delayed.
AbbVie Inc. over the past year
From daily closing prices. The highest close in the period was 294.89 USD on 30 Oct 2026, the lowest 197.38 USD on 27 Apr 2026.
| 1 month | 3 months | 6 months | Year to date | 1 year |
|---|---|---|---|---|
| +9.86% | +18.43% | +40.09% | +26.37% | +33.74% |
| Month | Close (USD) | Change |
|---|---|---|
| November 2026 | 288.73 | -2.09% |
| October 2026 | 294.89 | +12.73% |
| September 2026 | 261.59 | +2.02% |
| August 2026 | 256.42 | +2.18% |
| July 2026 | 250.94 | -0.28% |
| June 2026 | 251.64 | +15.58% |
| May 2026 | 217.72 | +3.03% |
| April 2026 | 211.32 | -2.84% |
| March 2026 | 217.49 | -6.29% |
| February 2026 | 232.08 | +4.07% |
| January 2026 | 223.01 | -2.40% |
| December 2025 | 228.49 | +0.35% |
Health care peers
AbbVie Inc. is on the S&P 500 heatmap (Health care). How it compares with the other health care stocks there, by market cap:
| Company | Today | Market cap | P/E |
|---|---|---|---|
| Eli Lilly and Company LLY | -0.11% | 1.26T USD | 45.7 |
| Johnson & Johnson JNJ | -1.62% | 641B USD | 40.4 |
| AbbVie Inc. ABBV | -0.98% | 505B USD | 49.1 |
| UnitedHealth Group Incorporated UNH | +1.00% | 363B USD | 23.1 |
| Merck & Co., Inc. MRK | -2.49% | 357B USD | 146.1 |
| Thermo Fisher Scientific Inc. TMO | +2.30% | 259B USD | 36.8 |
| Abbott Laboratories ABT | -0.69% | 191B USD | 40.7 |
| Intuitive Surgical, Inc. ISRG | +0.89% | 156B USD | 53.3 |
More on ABBV
Open ABBV in zysk for the live chart, news, earnings and dividends, and ask the AI why it moved: it answers in a few lines with sources and a chart (how zysk's AI stock research works). zysk explains facts, news and risks; it is not investment advice.